Search

Christine T Mui

Examiner (ID: 15280, Phone: (571)270-3243 , Office: P/1797 )

Most Active Art Unit
1797
Art Unit(s)
1777, 1709, 1797, 1774
Total Applications
1416
Issued Applications
1043
Pending Applications
77
Abandoned Applications
296

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5827024 [patent_doc_number] => 20060062798 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-23 [patent_title] => 'Vaccines' [patent_app_type] => utility [patent_app_number] => 10/515872 [patent_app_country] => US [patent_app_date] => 2003-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 5860 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0062/20060062798.pdf [firstpage_image] =>[orig_patent_app_number] => 10515872 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/515872
Vaccines May 22, 2003 Abandoned
Array ( [id] => 6966495 [patent_doc_number] => 20050233392 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-20 [patent_title] => 'Diagnosis of hepatocellular carcinoma' [patent_app_type] => utility [patent_app_number] => 10/514294 [patent_app_country] => US [patent_app_date] => 2003-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8550 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20050233392.pdf [firstpage_image] =>[orig_patent_app_number] => 10514294 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/514294
Diagnosis of hepatocellular carcinoma May 21, 2003 Issued
Array ( [id] => 903701 [patent_doc_number] => 07335747 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-02-26 [patent_title] => 'Cancer associated gene mina 53, protein Mina 53 and monoclonal antibody thereof' [patent_app_type] => utility [patent_app_number] => 10/509073 [patent_app_country] => US [patent_app_date] => 2003-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 13 [patent_no_of_words] => 20071 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/335/07335747.pdf [firstpage_image] =>[orig_patent_app_number] => 10509073 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/509073
Cancer associated gene mina 53, protein Mina 53 and monoclonal antibody thereof Apr 13, 2003 Issued
Array ( [id] => 6977810 [patent_doc_number] => 20050287528 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-29 [patent_title] => 'Methods for detecting ovarian cancer' [patent_app_type] => utility [patent_app_number] => 10/510321 [patent_app_country] => US [patent_app_date] => 2003-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 19874 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20050287528.pdf [firstpage_image] =>[orig_patent_app_number] => 10510321 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/510321
Methods for detecting ovarian cancer Apr 3, 2003 Abandoned
Array ( [id] => 151930 [patent_doc_number] => 07683159 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-03-23 [patent_title] => 'Tenascin-W compositions and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/509009 [patent_app_country] => US [patent_app_date] => 2003-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13879 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/683/07683159.pdf [firstpage_image] =>[orig_patent_app_number] => 10509009 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/509009
Tenascin-W compositions and uses thereof Mar 25, 2003 Issued
Array ( [id] => 197124 [patent_doc_number] => 07638619 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-12-29 [patent_title] => 'Variable region gene of heavy/light chain of anti-human hepatoma monoclonal antibody HAb 18 and use thereof' [patent_app_type] => utility [patent_app_number] => 10/507941 [patent_app_country] => US [patent_app_date] => 2003-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 12 [patent_no_of_words] => 6597 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/638/07638619.pdf [firstpage_image] =>[orig_patent_app_number] => 10507941 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/507941
Variable region gene of heavy/light chain of anti-human hepatoma monoclonal antibody HAb 18 and use thereof Mar 16, 2003 Issued
Array ( [id] => 7103414 [patent_doc_number] => 20050106140 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-19 [patent_title] => 'Antagonistic anti-hfas ligand human antibodies and fragments thereof' [patent_app_type] => utility [patent_app_number] => 10/506743 [patent_app_country] => US [patent_app_date] => 2003-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12295 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20050106140.pdf [firstpage_image] =>[orig_patent_app_number] => 10506743 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/506743
Antagonistic anti-hFAS ligand human antibodies and fragments thereof Mar 11, 2003 Issued
Array ( [id] => 5648384 [patent_doc_number] => 20060134116 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-22 [patent_title] => 'Ca 125 tumor antigen function and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/507728 [patent_app_country] => US [patent_app_date] => 2003-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 49 [patent_figures_cnt] => 49 [patent_no_of_words] => 13932 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0134/20060134116.pdf [firstpage_image] =>[orig_patent_app_number] => 10507728 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/507728
Ca 125 tumor antigen function and uses thereof Mar 10, 2003 Abandoned
Array ( [id] => 7313269 [patent_doc_number] => 20040033542 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-19 [patent_title] => 'Shc protein-related methods and compositions for the prognosis of breast, prostate and ovarian cancer' [patent_app_type] => new [patent_app_number] => 10/376538 [patent_app_country] => US [patent_app_date] => 2003-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 14638 [patent_no_of_claims] => 70 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0033/20040033542.pdf [firstpage_image] =>[orig_patent_app_number] => 10376538 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/376538
Shc protein-related methods and compositions for the prognosis of breast, prostate and ovarian cancer Feb 27, 2003 Issued
Array ( [id] => 7362467 [patent_doc_number] => 20040005294 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-08 [patent_title] => 'IGFBP-3 in the diagnosis and treatment of cancer' [patent_app_type] => new [patent_app_number] => 10/377142 [patent_app_country] => US [patent_app_date] => 2003-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 44987 [patent_no_of_claims] => 75 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0005/20040005294.pdf [firstpage_image] =>[orig_patent_app_number] => 10377142 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/377142
IGFBP-3 in the diagnosis and treatment of cancer Feb 24, 2003 Abandoned
Array ( [id] => 856946 [patent_doc_number] => 07375206 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-05-20 [patent_title] => 'Brother of the regulator of imprinted sites (BORIS)' [patent_app_type] => utility [patent_app_number] => 10/505377 [patent_app_country] => US [patent_app_date] => 2003-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 15229 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/375/07375206.pdf [firstpage_image] =>[orig_patent_app_number] => 10505377 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/505377
Brother of the regulator of imprinted sites (BORIS) Feb 20, 2003 Issued
Array ( [id] => 5922155 [patent_doc_number] => 20060240417 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-26 [patent_title] => 'Agent controlling the apoptosis induction by p73' [patent_app_type] => utility [patent_app_number] => 10/502449 [patent_app_country] => US [patent_app_date] => 2003-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 7699 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0240/20060240417.pdf [firstpage_image] =>[orig_patent_app_number] => 10502449 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/502449
Agent controlling the apoptosis induction by p73 Jan 22, 2003 Abandoned
Array ( [id] => 5643217 [patent_doc_number] => 20060281672 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-14 [patent_title] => 'Dec-205 (ly 75)/dcl-1 intergenic splice variants associated with hodgkin\'s disease, and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/537839 [patent_app_country] => US [patent_app_date] => 2002-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 23998 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20060281672.pdf [firstpage_image] =>[orig_patent_app_number] => 10537839 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/537839
Dec-205 (ly 75)/dcl-1 intergenic splice variants associated with hodgkin's disease, and uses thereof Dec 5, 2002 Abandoned
Array ( [id] => 8176776 [patent_doc_number] => 08178320 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-15 [patent_title] => 'Artificial antibody library with super-repertory' [patent_app_type] => utility [patent_app_number] => 10/496349 [patent_app_country] => US [patent_app_date] => 2002-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 14723 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 259 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/178/08178320.pdf [firstpage_image] =>[orig_patent_app_number] => 10496349 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/496349
Artificial antibody library with super-repertory Nov 21, 2002 Issued
Array ( [id] => 7361795 [patent_doc_number] => 20040091475 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-13 [patent_title] => 'Degraded tpo agonist antibody' [patent_app_type] => new [patent_app_number] => 10/399518 [patent_app_country] => US [patent_app_date] => 2003-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 50 [patent_figures_cnt] => 50 [patent_no_of_words] => 29291 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 25 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0091/20040091475.pdf [firstpage_image] =>[orig_patent_app_number] => 10399518 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/399518
Degraded TPO agonist antibody Oct 21, 2001 Issued
Array ( [id] => 267238 [patent_doc_number] => 07566764 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-07-28 [patent_title] => 'Truncated BARD1 protein, and its diagnostic and therapeutic uses' [patent_app_type] => utility [patent_app_number] => 10/363285 [patent_app_country] => US [patent_app_date] => 2001-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 4 [patent_no_of_words] => 6199 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/566/07566764.pdf [firstpage_image] =>[orig_patent_app_number] => 10363285 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/363285
Truncated BARD1 protein, and its diagnostic and therapeutic uses Sep 2, 2001 Issued
Array ( [id] => 5952244 [patent_doc_number] => 20020007051 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-01-17 [patent_title] => 'Use of multiple recombination sites with unique specificity in recombinational cloning' [patent_app_type] => new [patent_app_number] => 09/732914 [patent_app_country] => US [patent_app_date] => 2000-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 83521 [patent_no_of_claims] => 142 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0007/20020007051.pdf [firstpage_image] =>[orig_patent_app_number] => 09732914 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/732914
Use of multiple recombination sites with unique specificity in recombinational cloning Dec 10, 2000 Issued
Menu